"Through the 'elimination' or 'deferral' of expenditures no 'longer required' at this time, Unilife expects to reduce operating expenses by approximately $5 million during calendar year 2011"
"Unilife 'significantly expanded' its operational capabilities in order to meet the ''anticipated'' production requirements and stringent quality assurance expectations of current and prospective pharmaceutical customers."
"Unilife expects that as a result of this realignment, it 'could be' in a position to secure development, industrialization or exclusivity agreements with interested pharmaceutical parties that can support the commercialization of some of these pipeline products during the second half of 2011."
The above exerts, as gifter2 states "cryptic clues", one can only conclude, expectations were not met as quickly as anticipated...I think AS was starting to believe his own sales spiel...he sucked us all in. This is why the SP is where it is and not the other side of the $1 mark, imo. The use of "anticipated" & "could be" words seem very interesting to me..... & the big one "re-alignment" you usually use that when there is a big stuff-up!!
The doco could have been worded a little more professionally in my book, one can only try and read too much in to it.
PS. I thought "Unilean" was to take care of all this some months ago? What can I say... interesting piece. I do hope we hear some more.
:-)
UNS Price at posting:
85.5¢ Sentiment: Hold Disclosure: Held
